Mulay James
Insider CIK 1684531 · FLGT Director · CGON Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CGON CG Oncology, Inc. | M Exercise deriv | 2026-07-10 | 2026-07-14 | 24,165 | — | $0 | 0 | SEC↗ |
| CGON CG Oncology, Inc. | S Sale | 2026-07-10 | 2026-07-14 | 24,165 | $75.16 | $1.82M | 0 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise | 2026-07-10 | 2026-07-14 | 24,165 | $26.63 | $643.5K | 24,165 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise deriv | 2026-06-15 | 2026-06-16 | 1,310 | — | $0 | 2,620 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise deriv | 2026-06-15 | 2026-06-16 | 654 | — | $0 | 0 | SEC↗ |
| CGON CG Oncology, Inc. | S Sale | 2026-06-15 | 2026-06-16 | 654 | $60.12 | $39.3K | 0 | SEC↗ |
| CGON CG Oncology, Inc. | S Sale | 2026-06-15 | 2026-06-16 | 1,310 | $60.12 | $78.8K | 0 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise | 2026-06-15 | 2026-06-16 | 1,310 | $12.59 | $16.5K | 1,310 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise | 2026-06-15 | 2026-06-16 | 654 | $3.72 | $2.4K | 654 | SEC↗ |
| CGON CG Oncology, Inc. | A Award deriv | 2026-06-04 | 2026-06-05 | 9,354 | — | $0 | 9,354 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise deriv | 2026-04-17 | 2026-04-20 | 15,600 | — | $0 | 0 | SEC↗ |
| CGON CG Oncology, Inc. | S Sale | 2026-04-17 | 2026-04-20 | 15,600 | $73.01 | $1.14M | 0 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise | 2026-04-17 | 2026-04-20 | 15,600 | $36.63 | $571.4K | 15,600 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise deriv | 2026-03-16 | 2026-03-17 | 1,310 | — | $0 | 3,930 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise deriv | 2026-03-16 | 2026-03-17 | 654 | — | $0 | 654 | SEC↗ |
| CGON CG Oncology, Inc. | S Sale | 2026-03-16 | 2026-03-17 | 1,310 | $63.50 | $83.2K | 0 | SEC↗ |
| CGON CG Oncology, Inc. | S Sale | 2026-03-16 | 2026-03-17 | 654 | $63.50 | $41.5K | 0 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise | 2026-03-16 | 2026-03-17 | 654 | $3.72 | $2.4K | 654 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise | 2026-03-16 | 2026-03-17 | 1,310 | $12.59 | $16.5K | 1,310 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise deriv | 2026-01-09 | 2026-01-13 | 654 | — | $0 | 1,308 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise deriv | 2026-01-09 | 2026-01-13 | 10,491 | — | $0 | 5,240 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise | 2026-01-09 | 2026-01-13 | 10,491 | $12.59 | $132.1K | 10,491 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise | 2026-01-09 | 2026-01-13 | 654 | $3.72 | $2.4K | 654 | SEC↗ |
| CGON CG Oncology, Inc. | S Sale | 2026-01-09 | 2026-01-13 | 654 | $44.16 | $28.9K | 0 | SEC↗ |
| CGON CG Oncology, Inc. | S Sale | 2026-01-09 | 2026-01-13 | 10,491 | $52.99 | $555.9K | 0 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise deriv | 2025-10-09 | 2025-10-10 | 5,903 | — | $0 | 1,962 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise | 2025-10-09 | 2025-10-10 | 5,903 | $3.72 | $22.0K | 5,903 | SEC↗ |
| CGON CG Oncology, Inc. | S Sale | 2025-10-09 | 2025-10-10 | 5,903 | $43.99 | $259.7K | 0 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise deriv | 2025-09-29 | 2025-09-30 | 12,755 | — | $0 | 0 | SEC↗ |
| CGON CG Oncology, Inc. | S Sale | 2025-09-29 | 2025-09-30 | 12,755 | $39.19 | $499.9K | 0 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise | 2025-09-29 | 2025-09-30 | 12,755 | $1.82 | $23.2K | 12,755 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise deriv | 2025-09-19 | 2025-09-22 | 3,574 | — | $0 | 12,755 | SEC↗ |
| CGON CG Oncology, Inc. | S Sale | 2025-09-19 | 2025-09-22 | 3,574 | $38.99 | $139.4K | 0 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise | 2025-09-19 | 2025-09-22 | 3,574 | $1.82 | $6.5K | 3,574 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise deriv | 2025-09-18 | 2025-09-22 | 19,112 | — | $0 | 16,329 | SEC↗ |
| CGON CG Oncology, Inc. | S Sale | 2025-09-18 | 2025-09-22 | 19,112 | $39.01 | $745.6K | 0 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise | 2025-09-18 | 2025-09-22 | 19,112 | $1.82 | $34.8K | 19,112 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise deriv | 2025-09-05 | 2025-09-08 | 27,015 | — | $0 | 0 | SEC↗ |
| CGON CG Oncology, Inc. | S Sale | 2025-09-05 | 2025-09-08 | 12,342 | $30.47 | $376.1K | 14,673 | SEC↗ |
| CGON CG Oncology, Inc. | S Sale | 2025-09-05 | 2025-09-08 | 4,095 | $31.42 | $128.7K | 10,578 | SEC↗ |
| CGON CG Oncology, Inc. | S Sale | 2025-09-05 | 2025-09-08 | 7,465 | $32.64 | $243.7K | 3,113 | SEC↗ |
| CGON CG Oncology, Inc. | M Exercise | 2025-09-05 | 2025-09-08 | 27,015 | $0.60 | $16.2K | 27,015 | SEC↗ |
| CGON CG Oncology, Inc. | S Sale | 2025-09-05 | 2025-09-08 | 3,113 | $33.22 | $103.4K | 0 | SEC↗ |
| CGON CG Oncology, Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 24,165 | — | $0 | 24,165 | SEC↗ |
| CGON CG Oncology, Inc. | A Award deriv | 2024-10-04 | 2024-10-07 | 15,600 | — | $0 | 15,600 | SEC↗ |
| FLGT Fulgent Genetics, Inc. | A Award deriv | 2019-05-30 | 2019-06-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| FLGT Fulgent Genetics, Inc. | A Award deriv | 2018-05-18 | 2018-05-21 | 5,000 | — | $0 | 5,000 | SEC↗ |
| FLGT Fulgent Genetics, Inc. | A Award | 2017-05-16 | 2017-06-12 | 2,000 | — | $0 | 10,000 | SEC↗ |
| FLGT Fulgent Genetics, Inc. | A Award | 2016-10-26 | 2016-10-28 | 8,000 | — | $0 | 8,000 | SEC↗ |